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formation on heart failure. Patients with renal failure often suffer 
from atherosclerotic lesions and, not surprisingly, do often have 
elevated troponins and catecholamines. Furthermore, heart fail-
ure is a known condition causing elevated troponin  [10] . Patients 
with heart failure are at increased risk of suffering an ischemic 
stroke.
 Thirdly, the definition of myocardial infarction relies on the 
fact that serial, i.e. at least two, measurements of biomarkers (tro-
ponin and/or CK-MB) are obtained so that a rise-and-fall pat-
tern – a prerequisite for diagnosis – can be detected  [11] .
 Since the coexistence of coronary artery disease has a strong 
impact on the long-term prognosis of cerebrovascular patients, 
those with elevated levels of troponins should be routinely sched-
uled for further cardiac evaluation in order to identify or rule out 
any possibly coexisting coronary artery disease. The problem 
with the neuromediated theory is that the patients will not be 
evaluated by a cardiologist if elevation of troponin is detected. 
 In a recent issue of  Cerebrovascular Diseases , Barber et al.  [1] 
attempted to identify the link between sympathetic nervous ac-
tivity and myocardial cell damage in patients with acute ischemic 
stroke. They studied 222 consecutive acute ischemic stroke ad-
missions within 24 h of symptom debut. Troponin I, catechol-
amines and a 12-lead resting ECG were measured once. Elevated 
levels of troponin I ( 1 0.2   g/l) were detected in 20% of the pa-
tients. These patients had higher levels of epinephrine and were 
more likely to have ECG changes suggestive of acute myocardial 
infarction (AMI). The authors concluded that their findings were 
consistent with activation of the sympathetic nervous system 
leading to myocytolysis.
 We applaud the authors for attempting to demonstrate what 
may well be a valid assumption. The theory of neuromediated 
myocardial cell damage (due to, at least in part, elevated catechol-
amines) has been repeatedly proposed for several years mostly in 
patients with subarachnoid hemorrhage and intracranial bleed-
ings  [2, 3] . However, there are several additional considerations to 
the authors’ conclusions.
 Firstly, their analysis is retrospective and when reading their 
inclusion and exclusion criteria there is no information regarding 
patients which might have had symptoms of AMI days or hours 
ahead of the cerebrovascular event  [1, 4] . In this context, it is im-
portant to remember that following AMI the incidence of isch-
emic stroke is markedly increased, particularly during the first 30 
days after the cardiac index event  [5–7] . Troponin can stay elevat-
ed as long as 2 (  3) weeks after an AMI depending on the size  [8] . 
Therefore the ECG changes and elevated levels of troponin I could 
be a result of recent AMI which per se can lead to elevated levels 
of catecholamines. Ischemic heart disease in the elderly may in 
fact go unnoticed due to absence of symptoms, memory impair-
ment and/or diminished physical activity  [9] . Indeed, up to 25 % 
of AMIs are asymptomatic. This problem may even be worse in 
patients with stroke due to cognitive and language impairments. 
The authors demonstrated that, in their study, patients with ele-
vated troponin I were older and the stroke was more severe.
 Secondly, troponins can be raised due to a number of other 
conditions, e.g. renal insufficiency and heart failure  [10] . In the 
study by Barber et al. [1] a higher frequency of patients with ele-
vated levels of troponin I had renal failure, while there is no in-
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